Your browser doesn't support javascript.
loading
Carbon dioxide laser combined with botulinum toxin A for patients with periorbital syringomas.
Seo, Hyun-Min; Choi, Ju-Yeon; Min, Jung; Kim, Won-Serk.
Afiliación
  • Seo HM; a Department of Dermatology , Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine , Seoul , Korea.
  • Choi JY; a Department of Dermatology , Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine , Seoul , Korea.
  • Min J; a Department of Dermatology , Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine , Seoul , Korea.
  • Kim WS; a Department of Dermatology , Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine , Seoul , Korea.
J Cosmet Laser Ther ; 18(3): 149-53, 2016 Jun.
Article en En | MEDLINE | ID: mdl-26073121
ABSTRACT

BACKGROUND:

Although various destructive methods have been described for treating syringomas, they are often associated with significant scarring and recurrence. In 2007, multiple-drilling method using carbon dioxide (CO2) laser was introduced as an alternative modality to gain good cosmetic results.

OBJECTIVE:

To retrospectively evaluate the effectiveness of CO2 laser combined with botulinum toxin A (BTXA) as treatment for syringomas. MATERIAL AND

METHODS:

Forty-eight patients with periorbital syringomas were treated with topical application of BTXA immediately after CO2 laser treatment. Forty-four patients were treated with CO2 laser only.

RESULTS:

Patients who were treated with CO2 laser combined with BTXA required significantly (p = 0.038) fewer treatment sessions compared with those treated with CO2 laser only. When the clinical improvements of the two treatment sessions were compared, the combined therapy (CO2 laser and BTXA) had significantly (p = 0.044) higher rate of results showing good (disappearance of 60-80% of lesion) or excellent (80-100%) than the CO2 laser only therapy (87.5% vs. 70.5%).

CONCLUSIONS:

CO2 laser combined with BTXA showed better effect than CO2 laser only.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de las Glándulas Sudoríparas / Siringoma / Toxinas Botulínicas Tipo A / Neoplasias de los Párpados / Terapia por Láser / Fármacos Neuromusculares Límite: Female / Humans / Male Idioma: En Año: 2016 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de las Glándulas Sudoríparas / Siringoma / Toxinas Botulínicas Tipo A / Neoplasias de los Párpados / Terapia por Láser / Fármacos Neuromusculares Límite: Female / Humans / Male Idioma: En Año: 2016 Tipo del documento: Article